Gast ::
| 001 | 784014 | ||
| 005 | 20250306130313.0 | ||
| 024 | 7 | _ | |2 HSB |a eva30190 |
| 024 | 7 | _ | |2 ISSN |a 1742-7835 |
| 024 | 7 | _ | |2 ISSN |a 1742-7843 |
| 024 | 7 | _ | |2 SCOPUS |a SCOPUS:2-s2.0-85064656864 |
| 024 | 7 | _ | |2 WOS |a WOS:000481768000008 |
| 024 | 7 | _ | |2 doi |a 10.1111/bcpt.13236 |
| 024 | 7 | _ | |2 pmid |a pmid:30925204 |
| 037 | _ | _ | |a RWTH-CONV-240972 |
| 041 | _ | _ | |a English |
| 100 | 1 | _ | |a Krabbe, Julia |b 0 |e Corresponding author |u rwth |
| 245 | _ | _ | |a Retrograde perfusion in isolated perfused mouse lungs-Feasibility and effects on cytokine levels and pulmonary oedema formation |h online, print |
| 260 | _ | _ | |c 2019 |
| 336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
| 336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |
| 336 | 7 | _ | |2 BibTeX |a ARTICLE |
| 336 | 7 | _ | |2 DRIVER |a article |
| 336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
| 336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
| 591 | _ | _ | |a Germany |
| 700 | 1 | _ | |a Ruske, Nadine |b 1 |u rwth |
| 700 | 1 | _ | |a Kanzler, Stephanie |b 2 |u rwth |
| 700 | 1 | _ | |a Reiss, Lucy Kathleen |b 3 |u rwth |
| 700 | 1 | _ | |a Ludwig, Andreas |b 4 |u rwth |
| 700 | 1 | _ | |0 P:(DE-82)IDM06240 |a Uhlig, Stefan |b 5 |u rwth |
| 700 | 1 | _ | |a Martin, Christian |b 6 |u rwth |
| 773 | _ | _ | |0 PERI:(DE-600)2151592-X |a 10.1111/bcpt.13236 |n 3 |p 279-288 |t Basic & clinical pharmacology & toxicology |v 125 |x 1742-7835 |
| 914 | 1 | _ | |y 2019 |
| 915 | 1 | _ | |0 StatID:(DE-HGF)0031 |2 StatID |a Peer reviewed article |x 0 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0030 |2 StatID |a Peer Review |b ASC |d 2022-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b BASIC CLIN PHARMACOL : 2021 |d 2022-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0113 |2 StatID |a WoS |b Science Citation Index Expanded |d 2022-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |d 2022-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0160 |2 StatID |a DBCoverage |b Essential Science Indicators |d 2022-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Clarivate Analytics Master Journal List |d 2022-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |d 2022-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |d 2022-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0600 |2 StatID |a DBCoverage |b Ebsco Academic Search |d 2022-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1030 |2 StatID |a DBCoverage |b Current Contents - Life Sciences |d 2022-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |d 2022-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1190 |2 StatID |a DBCoverage |b Biological Abstracts |d 2022-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)3001 |2 StatID |a DEAL Wiley |d 2022-11-13 |w ger |
| 915 | _ | _ | |0 StatID:(DE-HGF)9900 |2 StatID |a IF < 5 |d 2022-11-13 |
| 920 | 1 | _ | |0 I:(DE-82)528500-2_20140620 |k 528500-2 |l Institut und Lehrstuhl für Pharmakologie und Toxikologie |x 0 |
| 970 | _ | _ | |a eva30190 |
| 980 | _ | _ | |a I:(DE-82)528500-2_20140620 |
| 980 | _ | _ | |a IMPORT |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a VDBINPRINT |
| 980 | _ | _ | |a journal |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|